• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Strides Pharma Science Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16996.0
  • ISIN : INE939A01011
887.80 18 (2.02%)
  • As on 11 Jul 2025 (EOD)

  • Today’s Low

    872.35

  • Today’s High

    894.00

  • Open

    872.40

  • Perv Close

    870.25

  • 52W Low

    394.62

  • 52W High

    914.00

Key Indicators

  • P/E(TTM)

    138.23

  • Mar.Cap (₹Cr.)

    8,182.21

  • Div & Yield %

    0.45

  • Book Value(₹)

    346.42

  • Debt-Equity Ratio

    2.02

  • AGM Date

    11-Jul-2025

  • EPS

    6.42

  • P/E Ratio

    138.23

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    8,182.21

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    92.16

  • BV (₹)

    346.40

  • Sales( ₹ in Cr.)

    2,139.42

  • NP (in Cr.)

    59.19

  • NP Var(%)

    -16.0

  • Div%

    40.0

  • CPS (₹)

    15.60

  • EPS (₹)

    6.40

  • Traded Value (₹ in Lakhs)

    8,178.98

  • 52 Week High

    914.00

  • 52 Week Low

    394.62

  • Price BSE

    887.0

  • Price NSE

    888.00

  • Market Capital( in Cr.)

    8,178.98

  • P/C Ratio

    56.80

  • P/E Ratio

    138.10

  • Price Vs.BV

    6.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,153.26 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,153.26 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44
Other Income 72.31 84.07 123.49 117.09 93.07 114.61
Stock Adjustments -4.62 -21.04 -114.26 117.53 2.88 45.52
Total Income 2,220.95 1,917.53 1,988.23 2,092.19 1,787.88 1,697.57
EXPENDITURE :            
Raw Materials 1,101.85 1,044.57 987.26 1,106.41 894.84 924.35
Power and Fuel Cost 53.12 45.54 43.76 45.82 44.53 39.77
Employee Cost 335.21 267.01 272.09 272.72 230.23 223.21
Other Manufacturing Expenses 144.83 130.03 151.87 134.86 117.43 76.00
Selling and Administration Expenses 168.38 182.64 260.83 171.51 117.95 132.91
Miscellaneous Expenses 95.34 80.19 72.31 84.56 85.37 55.24
Employee Benefit Expenses 335.21 267.01 272.09 272.72 230.23 223.21
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,898.72 1,749.98 1,788.12 1,815.87 1,490.35 1,451.48
Operating Profit 322.22 167.54 200.11 276.32 297.53 246.08
Interest 167.93 138.68 74.24 65.34 66.84 54.09
Gross Profit 154.29 28.86 125.87 210.98 230.69 191.99
Depreciation 84.67 93.62 104.37 99.34 94.24 83.00
Profit Before Tax 69.62 -64.76 21.50 111.64 136.45 108.99
Current Tax 0.31 -49.84 -169.66 33.65 18.76 0.58
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.82 -19.60 10.98 -0.26 -2.59 -1.96
Reported Net Profit 65.49 4.68 180.19 78.24 120.28 110.37
Extraordinary Items -5.37 -16.32 4.23 3.26 3.41 3.86
Adjusted Net Profit 70.86 21.00 175.96 74.98 116.87 106.51
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -57.25 -9.30
P & L Balance brought forward 745.57 740.89 583.13 522.80 616.08 532.93
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.55 0.00 22.43 17.91 156.30 17.91
P & L Balance carried down 797.51 745.57 740.89 583.13 522.80 616.08
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 15.00 0.00 25.00 140.00 30.00
Dividend Per Share(Rs) 2.50 1.50 0.00 2.50 14.00 3.00
Earnings Per Share-Unit Curr 7.13 0.52 20.07 8.72 13.43 12.32
Earnings Per Share(Adj)-Unit Curr 3.12 0.23 8.79 3.82 5.88 5.40
Book Value 387.49 380.71 379.36 362.18 352.68 363.69
Book Value(Adj)-Unit Curr 169.80 166.83 166.24 158.71 154.54 159.37

Shareholding Pattern

  • Promoter Group

    28.30%

  • Public Share Holding

    71.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 240,860 0.26 240,860 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,108,899 4.46 4,108,899 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 300,000 0.33 300,000 1
Others 0 0.00 0 0
Sub Total 26,077,845 28.30 26,077,845 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,125 0.01 8,125 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,025 0.01 7,999 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,104,867 28.32 26,104,867 228
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,783,086 3.02 2,783,086 5
Mutual Funds / UTI 8,192,966 8.89 8,192,966 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,658,322 1.80 1,658,322 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,756,391 42.05 38,755,365 268
2] Non Institution
Bodies Corporate 3,524,999 3.82 3,523,881 823
Clearing Members 0 0.00 0 0
Directors of their Relatives 55,000 0.06 55,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,009,067 2.18 2,007,740 1,374
Foreign Non Institution Other 21,000 0.02 21,000 1
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,544,512 8.19 7,544,512 98
Individuals holding nominal share capital up to Rs. 1 lakh 12,284,284 13.33 12,220,393 89,320
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,889,616 2.05 1,889,460 3,225
Sub Total 27,328,478 29.65 27,261,986 94,842
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,162,714 100.00 92,095,196 95,125

Company Background

Strides Pharma Science LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Strides Pharma Science Ltd
  • BSE Code : 16996.0
  • ISIN : INE939A01011

  • Incorporation Year

    1990

  • Registered Office

    No 201 Devavrata Sector 17
    Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924/27893199

  • FAX

    91-22-27892942

  • Chairman

    Arun Kumar

  • Managing Director

    Badree Komandur

  • Company Secretary

    Manjula Ramamurthy

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Strides Pharma Science Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Strides Pharma 887.45 2,225.56 2,153.26 2.83 4.68
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10